Cargando…

Long Term Cardiovascular Outcome Based on Aspirin and Clopidogrel Responsiveness Status in Young ST-Elevated Myocardial Infarction Patients

BACKGROUND: A subset of patients who take antiplatelet therapy continues to have recurrent cardiovascular events which may be due to antiplatelet resistance. The effect of low response to aspirin or clopidogrel on prognosis was examined in different patient populations. OBJECTIVE: We aimed to invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Somuncu, Mustafa Umut, Demir, Ali Riza, Karakurt, Seda Tukenmez, Karakurt, Huseyin, Karabag, Turgut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371821/ https://www.ncbi.nlm.nih.gov/pubmed/30570067 http://dx.doi.org/10.5935/abc.20180251

Ejemplares similares

The Relationship Between Aspirin Resistance and Carotid Imaging in Young Patients With ST-Segment Elevated Myocardial Infarction: A Cross-Sectional Study
por: Somuncu, Mustafa Umut, et al.
Publicado: (2018)

The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2019)

Microvolt T-wave alternans in young myocardial infarction patients with preserved cardiac function treated with single-vessel primary percutaneous coronary intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2016)

Pentraxin-3 is Associated with Adverse Diastolic Remodeling in Patients with ST-Elevation Myocardial Infarction after Successful Reperfusion by Primary Percutaneous Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2021)

Could sST2 Predict Contrast-Induced Nephropathy in ST-Segment Elevation Myocardial Infarction?
por: Avcı, Ahmet, et al.
Publicado: (2020)

Ischemic Modified Albumin Predicts Critical Coronary Artery Disease in Unstable Angina Pectoris and Non-ST-Elevation Myocardial Infarction
por: Demirtas, Abdullah Orhan, et al.
Publicado: (2018)

Change in left ventricular systolic function in patients with ST elevation myocardial infarction: Evidence for smoker's paradox or pseudo-paradox?
por: Acar, Burak, et al.
Publicado: (2016)

Pulmonary Alveolar Hemorrhage after Clopidogrel Use for ST Elevation Myocardial Infarction
por: Kim, Youngjoong, et al.
Publicado: (2013)

Small-Vessel Vasculitis After ST-Segment Elevation Myocardial Infarction: Clopidogrel or Amiodarone?
por: Lehr, Saskia, et al.
Publicado: (2022)

Asymptomatic Huge Cardiac Hydatid Cyst Located in the Interventricular Septum
por: İyigün, Taner, et al.
Publicado: (2020)

Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST‐Segment–Elevation Myocardial Infarctions
por: Schmucker, Johannes, et al.
Publicado: (2019)

Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan
por: Lee, Chih-Kuo, et al.
Publicado: (2021)

Von Willebrand Factor Antigen Predicts Response to Double Dose of Aspirin and Clopidogrel by PFA-100 in Patients Undergoing Primary Angioplasty for St Elevation Myocardial Infarction
por: Gianetti, Jacopo, et al.
Publicado: (2013)

Beneficial effects of combined administration of Clopidogrel and Aspirin on the levels of proinflammatory cytokines, cardiac function, and prognosis in ST-segment elevation myocardial infarction: A comparative study
por: Yu, Hai-Rong, et al.
Publicado: (2018)

Elective percutaneous coronary intervention leads to significant changes in serum resistin, leptin, and adiponectin levels regardless of periprocedural myocardial injury: an observational study
por: Buturak, Ali, et al.
Publicado: (2016)

Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis
por: Buturak, Ali, et al.
Publicado: (2016)

Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction
por: Pandey, Chandra Prakash, et al.
Publicado: (2019)

Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels
por: Borna, Catharina, et al.
Publicado: (2005)

Acute Myocardial Infarction Caused by Filgrastim: A Case Report
por: Bilir, Cemil, et al.
Publicado: (2012)

Evans syndrome with non-ST segment elevation myocardial infarction complicated by hemopericardium
por: Kizilirmak, Filiz, et al.
Publicado: (2016)

Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)
por: Tran, Huyen, et al.
Publicado: (2006)

Electrocardiographic changes in right ventricular metastatic cardiac tumor mimicking acute ST elevation myocardial infarction: A case of misdiagnosis
por: Demir, Vahit, et al.
Publicado: (2018)

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021)

Assessment of the Prophylactic Role of Aspirin and/or Clopidogrel on Experimentally Induced Acute Myocardial Infarction in Hypercholesterolemic Rats
por: Mohamed, Adham R., et al.
Publicado: (2014)

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Zhang, Xiaoyan, et al.
Publicado: (2019)

Aspirin and Clopidogrel Resistance
por: Sztriha, Laszlo K., et al.
Publicado: (2004)

Evaluation of Arterial Stiffness for Predicting Future Cardiovascular Events in Patients with ST Segment Elevation and Non-ST Segment Elevation Myocardial Infarction
por: Akkus, Oguz, et al.
Publicado: (2013)

Predictors of left ventricular ejection function decline in young patients with ST-segment elevation myocardial infarction
por: Yildiz, Ibrahim, et al.
Publicado: (2022)

Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors
por: Bugiardini, Raffaele, et al.
Publicado: (2020)

Protective Value of Aspirin Loading Dose on Left Ventricular Remodeling After ST-Elevation Myocardial Infarction
por: Calvieri, Camilla, et al.
Publicado: (2022)

The relationship of Charlson comorbidity index with stent restenosis and extent of coronary artery disease
por: Karabağ, Turgut, et al.
Publicado: (2018)

Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis
por: Vercellino, Matteo, et al.
Publicado: (2017)

A simple score for the prediction of stent thrombosis in patients with ST elevation myocardial infarction: TIMI risk index
por: Çınar, Tufan, et al.
Publicado: (2019)

Tombstoning ST-Elevation Myocardial Infarction
por: Balci, Bahattin
Publicado: (2009)

ST Elevation Myocardial Infarction in the elderly
por: Franken, Marcelo, et al.
Publicado: (2012)

Mistaken ST-Elevation Myocardial Infarction
por: Wolk, Brian J.
Publicado: (2015)

ST-elevation myocardial infarction in a patient with COVID-19
por: Eid, Mustafa Mahmood, et al.
Publicado: (2021)

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)

Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020)

COVID-19 TRIGGERED ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
por: Douedi, Steven, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l7q5jcpff8g8p14oue4o13fmu5